文献速递主动脉疾病内脏/肾动脉与血管畸形

定制开窗支架腔内修复近肾/肾旁及IV型胸腹主动脉瘤的近端主动脉覆盖与临床结果

Proximal Aortic Coverage and Clinical Results of the Endovascular Repair of Juxta-/Para-renal and Type IV Thoracoabdominal Aneurysm with Custom-made Fenestrated Endografts.
PubMed 文献 · Ann Vasc Surg · 2021-01-04

平均额外覆盖48±2 mm,技术成功率98%,30天死亡率1.4%,随访显示生存率、靶内脏血管通畅率和免于再干预率良好。

要点

  • 定制开窗支架修复近肾/肾旁/IV型胸腹主动脉瘤平均需额外覆盖近端健康主动脉48±2 mm。
  • 技术成功率98%,30天死亡率1.4%,脊髓缺血发生率0.7%。

核心结论

  • 定制开窗支架腔内修复近肾、肾旁及IV型胸腹主动脉瘤需平均额外覆盖近端健康主动脉48±2 mm,但未显示与不良早期及随访临床结局相关。

主要发现

  • 技术成功率达98%,失败包括1例III型内漏和2例肾动脉丢失。
  • 脊髓缺血发生率0.7%(1例,近端覆盖80 mm),肠缺血0.7%(1例),术后肾功能恶化24%。
  • 30天死亡率为1.4%,随访平均37±2个月无动脉瘤相关晚期死亡。
  • 1年、2年、5年生存率分别为94%、89%、75%,靶内脏血管通畅率分别为97%、97%、93%,免于再干预率分别为98%、95%、87%。

关键数值与推荐

  • 近端额外覆盖长度定义为定制开窗支架顶端与假设开放手术阻断水平间的距离(IV型胸腹主动脉瘤在腹腔干上,肾旁在肠系膜上动脉上,近肾在最低肾动脉上)。
  • 肾功能恶化定义为估算肾小球滤过率较基线下降>25%。
  • 技术成功定义为支架正确释放、靶内脏血管通畅、无I-III型内漏、无髂支狭窄/闭塞、无开放手术转换及24小时死亡。

临床怎么用

  • 在考虑近肾、肾旁及IV型胸腹主动脉瘤的定制开窗支架腔内修复适应证时,应评估近端额外主动脉覆盖长度。
  • 额外覆盖长度平均约48 mm,虽未显示与不良结局相关,但仍需个体化权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Juxta-renal (JAAA)/para-renal (PAAA) and type IV-thoracoabdominal (TAAA) aneurysms can be repaired by custom-made fenestrated endografts (CM-FEVAR). Differently from open repair, a relatively long segment of healthy proximal aorta needs to be covered to achieve a durable sealing, and this may be considered a disadvantage of the endovascular approach. We aimed to quantify the additional proximal aortic coverage in JAAAs, PAAAs, and type-IV TAAAs treated with CM-FEVAR and to evaluate its impact on early/follow-up clinical outcomes. METHODS: Between 2006 and 2018, preoperative, intraoperative, and postoperative data of JAAAs, PAAAs, and type-IV TAAAs submitted to CM-FEVAR were collected. The length of proximal healthy aortic coverage was evaluated on the preoperative endograft planning as the distance between the top of the CM-FEVAR endograft and the hypothetical level of aortic cross-clamping in case of open repair (type-IV TAAA-above the celiac trunk; PAAA-above the superior mesenteric artery; JAAA-above the lowest renal artery). Spinal cord ischemia (SCI), bowel ischemia (BI), renal function worsening (RFW) (estimated glomerular filtration rate reduction > 25% of the baseline level - RFW), and mortality were assessed at 30-day. Survival, target visceral vessel (TVV) patency, and freedom from reinterventions (FFRs) were assessed during follow-up by Kaplan-Meier analysis R2. RESULTS: One hundred forty-seven cases were submitted to CM-FEVAR, for 72 (49%) JAAAs, 46 (31%) PAAAs, and 29 (20%) type IV-TAAAs, with 1(4-3%), 2 (28-19%), 3 (48-33%), and 4 (67-45%) fenestrations. JAAAs required a fenestration + bridging stent graft for the superior mesenteric artery and celiac trunk, in 46(64%) and 24(33%) cases, respectively. Nineteen (41%) PAAAs required a fenestration + bridging stent graft for the celiac trunk. The mean proximal additional aortic coverage was 48 ± 2 mm with no differences among JAAAs (52 ± 1 mm), PAAAs (42 ± 2 mm), and type IV-TAAAs (50 ± 2 mm) (P.09). Technical success, defined as correct endograft deployment, with TVV patency, absence of type I-III endoleaks, iliac leg stenosis/occlusions, open surgical conversion, and 24-hour mortality, was achieved in 98% of cases. Failures occurred for 1 type-III endoleak (type-IV TAAA) and 2 renal artery losses (PAAA and type IV-TAAA). The only case of SCI (0.7%) occurred in a type-IV TAAA where the proximal healthy aortic coverage was 80 mm. One BI was caused by acute thrombosis of the bridging stent graft for the superior mesenteric artery at 24 hours in 1 type IV-TAAA (0.7%). Thirty-five patients (24%) suffered postoperative RFW and required hemodialysis in 1 (0.7%) JAAA with severe preoperative chronic renal failure. There was no difference of proximal additional aortic coverage between patients with (49 ± 29 mm) and without (48 ± 23 mm) RFW (P.2). The 30-day mortality was 1.4%. The mean follow-up was 37 ± 2 months with no cases of aneurysm-related late mortality. Survival was 94%, 89%, and 75% at 1, 2, and 5 years, respectively. TVV patency was 97%, 97%, and 93% at 1, 2, and 5 years, respectively. FFR was 98%, 95%, and 87% at 1, 2, and 5 years, respectively. CONCLUSIONS: Custom-made FEVAR requires a mean proximal additional aortic coverage of 48 ± 2 mm above the level of hypothetical aortic cross-clamping in case of open repair. This aspect should be considered for CM-FEVAR indication in JAAAs, PAAAs, and type-IV TAAAs; nevertheless, it does not appear to be associated with negative early and follow-up clinical sequelae.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Faggioli G, Pini R, et al. Proximal Aortic Coverage and Clinical Results of the Endovascular Repair of Juxta-/Para-renal and Type IV Thoracoabdominal Aneurysm with Custom-made Fenestrated Endografts. Ann Vasc Surg. 2021. PMID: 33412242. doi:10.1016/j.avsg.2020.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。